Quantcast

Latest Exosome Stories

2014-02-19 23:31:12

Colleen’s Dream Foundation has granted $11,000 to Memorial Sloan-Kettering Cancer Center to help fund ovarian cancer research being conducted by Dr. Vance Broach, according to Colleen’s Dream Foundation President Billy Cundiff. Phoenix, AZ (PRWEB) February 19, 2014 With the help of ovarian cancer survivor Jill Pall and NFL kicker Ryan Quigley, Colleen’s Dream Foundation has granted $11,000, to Memorial Sloan-Kettering Cancer Center to help fund ovarian cancer research being...

2014-01-13 04:20:54

GERMANTOWN, Maryland, and HILDEN, Germany, January 13, 2014 /PRNewswire/ -- - Expanding collaboration to develop FDA-regulated diagnostics based on exosomes to measure gene mutations targeted by new anti-cancer therapies - Non-invasive detection of biomarkers from blood reduces patient risk and advances access to the benefits of personalized medicine - Automated biofluid-based molecular diagnostics have significant potential to...

2014-01-13 04:20:53

-- Collaboration will focus on enabling detection of known cancer biomarkers in blood plasma NEW YORK, Jan. 13, 2014 /PRNewswire/ -- Exosome Diagnostics today announced an expansion of its strategic collaboration with QIAGEN to develop non-invasive molecular diagnostics for use in detecting and monitoring actionable genetic mutations in lung cancer patients. In contrast with current molecular diagnostics requiring tissue biopsy, the focus will be to enable detection of...

2014-01-09 11:35:24

Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer...

2013-12-13 23:04:48

New England Peptide (NEP), a Massachusetts based biotech manufacturer, and The Atlantic Cancer Research Institute (ACRI), a leading cancer research center in Atlantic Canada, have launched a new biotech company. Excipio Technologies Inc. has a mandate to commercialize the Vn96 peptide developed by both NEP and ACRI for the isolation of exosomes and extracellular microvesicles. Gardner, MA (PRWEB) December 13, 2013 Vn96 is a synthetic peptide that was designed to specifically stick to...

Anthrax Mystery Resolved
2013-11-14 15:12:09

Brett Smith for redOrbit.com - Your Universe Online For years, doctors have wondered why someone with an anthrax infection can die days after the bacteria responsible is wiped out from their body. A new study claims the toxin produced by the bacteria uses a “Trojan horse”-like method to elude the body’s natural defenses. "This remained a mystery for more than 50 years,” said study author Gisou van der Goot, a cell biologist at Switzerland's prestigious École Polytechnique...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related